Skip to main content

IBU News (Page 2)

FDA Medwatch Alert: Non-aspirin Nonsteroidal Anti-inflammatory Drugs (NSAIDs): Drug Safety Communication - FDA Strengthens Warning of Increased Chance of Heart Attack or Stroke

[Posted 07/09/2015] ISSUE:  FDA is strengthening an existing label warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) increase the chance of a heart attack or stroke. Based on ...

FDA Medwatch Alert: Prescription and Over-the-Counter (OTC) Pain Medicines: Drug Safety Communication - FDA Review of Possible Risks of Pain Medicine Use During Pregnancy

[Posted 01/09/2015] ISSUE:  FDA is aware of and understands the concerns arising from recent reports questioning the safety of prescription and over-the-counter (OTC) pain medicines when used ...

FDA Medwatch Alert: Ibuprofen and Oxcarbazepine Tablets by American Health Packaging: Recall - Mislabeled Packaging

ISSUE: American Health Packaging (AHP) voluntarily recalled Lot #142588, Expiration Date, 01/2016 of Ibuprofen Tablets, USP, 600 mg, in a hospital unit dose presentation that may contain individual...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Back Pain, Chronic Myofascial Pain, Aseptic Necrosis, Pain, Headache, Gout - Acute, Fever, Juvenile Rheumatoid Arthritis, Spondylolisthesis, view more... Dysautonomia, Frozen Shoulder, Muscle Pain, Neck Pain, Osteoarthritis, Period Pain, Dysmenorrhea, Plantar Fasciitis, Polymyalgia Rheumatica, Rheumatoid Arthritis, Sciatica, Temporomandibular Joint Disorder

IBU patient information at Drugs.com